Anemi tedavisinde gen düzenleme çalışmaları
Gene Editing · 2020
DOI: 10.29228/genediting.40385 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gene Editing, 2020. Verfasst von Fatih Kocabas- Batuhan Mert Kalkan und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
The novel approach called genome editing has been widely used in the research field of gene therapy, functional genomics and development of transgenic organisms for the past years.Gene editing is simply based on the usage of engineered, programmable and target specific nucleases inducing point specific modifications in the genome.These programmable nucleases are composed of a motive or sequence specific DNA binding domain and a DNA cleavage domain.DNA cleavage domain creates a double strand break (DSB) and facilitates the generation of insertions, deletions and substitutions desired at the genomic site of interest.Various platforms of engineered nucleases have been in use for genome editing studies.One of the most widely used and pioneer gene editing system is Zinc Finger Nucleases (ZFNs) (Bhakta, et al.
Zitieren
APA
Kalkan, F. K. B. M., & Nozhatzadeh, G. D. (2020). Anemi tedavisinde gen düzenleme çalışmaları. Gene Editing. https://doi.org/10.29228/genediting.40385
Vancouver
Kalkan FKBM, Nozhatzadeh GD. Anemi tedavisinde gen düzenleme çalışmaları. Gene Editing. 2020. doi:10.29228/genediting.40385
BibTeX
@article{Kalkan2020,
author = {Kalkan, Fatih Kocabas- Batuhan Mert and Nozhatzadeh, Gulcin Delal},
title = {Anemi tedavisinde gen düzenleme çalışmaları},
journal = {Gene Editing},
year = {2020},
doi = {10.29228/genediting.40385}
}
EUVIMED